Recent Finacing
Recent Raise
Augmenix develops minimally invasive, absorbable hydrogel implants—SpaceOAR to create rectal spacing during prostate radiotherapy and TraceIT as an imaging-visible tissue marker for improved radiation targeting.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
